A new drug for the treatment of narcolepsy and obstructive sleep apnea is coming to market in Germany in the form of Solriamfetol 75mg and 150mg film-coated tablets. Solriamfetol is a psychoanaleptic that inhibits the reuptake of dopamine and noradrenaline.
Solriamfetol film-coated tablets for narcolepsy and sleep apnea
May 13, 2020 | Medicines